Boothbay Fund Management »

Eyepoint Pharmaceuticals shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.1M 248k 20.67
2023-09-30 $744k 93k 7.99
2021-06-30 $347k 39k 9.00
2021-03-31 $145k 14k 10.19

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ishares Bitcoin Tr SHS (IBIT)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Grayscale Bitcoin Tr Btc Shs Rep Com Ut (GBTC)
Microstrategy Cl A New Put Option (MSTR)
Bitwise Bitcoin Etf Tr Shs Ben Int (BITB)
Sarepta Therapeutics Put Option (SRPT)
Spdr Ser Tr S&p Biotech Put Option (XBI)
United States Steel Corporation (X)
NVIDIA Corporation Call Option (NVDA)
Cornerstone Strategic Value (CLM)
Amazon Put Option (AMZN)
Humana Call Option (HUM)
Amphenol Corp Cl A Put Option (APH)

View all positions for Boothbay Fund Management

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
Adage Capital Partners GP
BlackRock
Franklin Resources
Vanguard Group
T. Rowe Price Associates
Morgan Stanley
T. Rowe Price Investment Management
Citadel Advisors
Essex Woodlands Health Ventures
State Street Corporation
Octagon Capital Advisors
Laurion Capital Management
Geode Capital Management

View all funds holding Eyepoint Pharmaceuticals